Botanical species · safety record

Momordica balsamina

The EFSA Compendium of Botanicals holds 11 constituent measurements for Momordica balsamina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Momordica balsamina L.

11Constituent measurements
0Safety records
5Cited sources
18Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 18 licensed products naming Momordica balsamina as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Fresh fruits collected just before ripening
  • Fruit
  • Fruit harvested just before ripe
  • Fruit(s)

What the records describe

Constituents measured

  • Alkaloids2
  • Anthraquinones1
  • Calcium oxalate1
  • Cucurbitacins1
  • Cyanide1
  • Momordin1
  • Oxalates1
  • Phytic acid1
  • Saponins1
  • Tannins1

Plant parts

  • Seed5
  • Fruit unspecified3
  • Stem3
  • stalk3

Preparations

  • Solvent extraction10
  • Fresh1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsStem / stalkSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier
AnthraquinonesStem / stalkSolvent extractionPhytochemical screeningNo resolvable identifier
Calcium oxalateFruit unspecifiedFreshMicroscopical and histometrical testsNo resolvable identifier
CucurbitacinsSeedSolvent extractionUnspecifiedNo resolvable identifier
CyanideSeedSolvent extraction0.2 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
MomordinSeedSolvent extractionUnspecifiedNo resolvable identifier
OxalatesSeedSolvent extraction0.9 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Phytic acidSeedSolvent extraction0.2 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsStem / stalkSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Faujdar, S., Paliwal, S.K., Mehta, S., Kalia, A.N. Pharmacognostical and phytochemical evaluation of Momordica balsamina fruits. International Journal of Pharmaceutical Sciences Review and Research, 2013, vol. 19, no. 2, p. 77-79.
  2. Ortigao, Marcelo., Better, Marc. Momordin II, a ribosome inactivating protein from Momordica balsamina, is homologous to other plant proteins. Nucleic acids research, 1992.
  3. Karaye, I.U., Aliero, A.A., Muhammad, S., Bilbis, L.S. Evaluation of nutrient and anti-nutrient contents of selected Nigerian cucurbits seeds. Research journal of pharmaceutical, biological and chemical sciences, 2013, vol. 4, no. 1, p. 137-142.
  4. Karawya, M. S., El-Gengaihi, S., Selim, M. A., Motawe, H. M., Ibrahim, N. A. Major cucurbitacins of Momordica balsamina. Pharmazie, 1996, p. 434-435.
  5. Akinyemi, K. O., Mendie, U. E., Smith, S. T., Oyefolu, A. O., Coker, A. O. Screening of some medicinal plants used in south-west Nigerian traditional medicine for anti-Salmonella typhi activity. Journal of Herbal Pharmacotherapy, 2005, vol. 5, no. 1, p. 45-60.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue